Rapporto sull’analisi delle dimensioni e delle quote del mercato della tecnologia di perfusione medica | Previsioni 2031

  • Report Code : TIPRE00019844
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 173
Buy Now

Si prevede che il mercato della tecnologia di perfusione medica raggiungerà i 962,60 milioni di dollari entro il 2027 rispetto ai 707,10 milioni di dollari del 2019. Si stima che il mercato crescerà a un CAGR del 4,1% dal 2020 al 2027.

L'ambito del mercato della tecnologia di perfusione medica comprende tecnica, tipo di organo, componente e regione. Il mercato della tecnologia di perfusione medica, in base alla regione, è segmentato in Nord America, Europa, Asia Pacifico, Medio Oriente e Asia. Africa e America meridionale e centrale. Il rapporto offre approfondimenti e analisi approfondite del mercato della tecnologia di perfusione medica, sottolineando vari parametri quali tendenze di mercato, progressi tecnologici, dinamiche di mercato e analisi del panorama competitivo dei principali attori del mercato in tutto il mondo. Include anche l'analisi dell'impatto del COVID-19 in tutte le regioni.

Regioni redditizie per il mercato della tecnologia di perfusione medica


Approfondimenti di mercato

Strumenti di perfusione per attività di ricerca basate sulle cellule

L'aumento delle condizioni croniche e i vantaggi delle applicazioni della biotecnologia stanno stimolando ampiamente le attività di ricerca basate sulle cellule. I test cellulari svolgono un ruolo fondamentale nella comprensione delle varie sfide della biologia degli organismi viventi, come la segnalazione cellulare, la proliferazione, l'apoptosi, la genetica cellulare, la neurologia e il cancro.

I test cellulari sono ampiamente condotto nelle industrie farmaceutiche e biotecnologiche, negli istituti di ricerca e negli istituti di ricerca accademici. Le industrie farmaceutiche e biofarmaceutiche utilizzano test cellulari per commercializzare in modo efficiente un farmaco.

I test cellulari vengono anche ampiamente eseguiti da organizzazioni di ricerca a contratto per studi di sperimentazione clinica e altri processi. Malattie croniche come il cancro e altri studi genetici stanno accelerando la domanda di studi basati sulle cellule. Ad esempio, Charles River offre servizi per test basati su cellule primarie umane. Secondo un articolo pubblicato dall'azienda, è probabile che gli sviluppi nei test cellulari continuino in futuro. Inoltre, l'azienda afferma che i test cellulari sono utili nella scoperta di farmaci poiché la correlazione in vitro e in vivo svolge un ruolo vitale nello sviluppo del farmaco. Pertanto, è probabile che le crescenti attività di ricerca basata sulle cellule guideranno il mercato della tecnologia di perfusione medica durante il periodo di previsione.

Approfondimenti basati sulla tecnica

Basato sulla tecnica, il mercato della tecnologia di perfusione medica è segmentato in macchina di perfusione ipotermica e macchina di perfusione normotermica. Il segmento delle macchine per perfusione ipotermica ha detenuto una quota maggiore del mercato nel 2019. Tuttavia, si stima che il segmento delle macchine per perfusione normotermiche registrerà un CAGR più elevato del 4,4% nel mercato durante il periodo di previsione.


Globale Mercato della tecnologia di perfusione medica, per tecnica - 2019 e 2027


Approfondimenti basati sul tipo di organo

In base al tipo di organo, il mercato della tecnologia di perfusione medica è segmentato in cuore, polmone e rene e fegato. Il segmento renale ha detenuto la quota maggiore del mercato nel 2019. Tuttavia, si stima che il segmento cardiaco registrerà il CAGR più elevato, pari al 4,8%, nel mercato durante il periodo di previsione.


Basato sui componenti Approfondimenti

In base ai componenti, il mercato della tecnologia di perfusione medica è segmentato in pompe di perfusione, ossigenatori, macchine cuore-polmone, sistemi di monitoraggio, cannule e altri. Nel 2019, il segmento degli ossigenatori deteneva la quota maggiore del mercato, per componente. Inoltre, si prevede che il segmento crescerà al ritmo più rapido nei prossimi anni a causa del crescente numero di interventi chirurgici cardiovascolari, trapianti di fegato e trapianti di rene.

Approfondimenti strategici

Strategie inorganiche come partnership, fusioni e amp; le acquisizioni sono comunemente adottate dalle aziende per soddisfare le mutevoli richieste dei clienti e mantenere il proprio marchio in tutto il mondo. Gli operatori di mercato che operano nel mercato della tecnologia di perfusione medica adottano anche strategie organiche come il lancio e l'espansione dei prodotti per ampliare la propria presenza e il portafoglio di prodotti in tutto il mondo e per soddisfare la crescente domanda.

< p>Per tecnica

  • Perfusione meccanica ipotermica
  • Perfusione meccanica normotermica

Per tipo di organo

  • Cuore
  • Polmone
  • Rene
  • Fegato
  • Altri

Per componente

  • Pompe per perfusione
  • Ossigenatori
  • Macchine cuore-polmone
  • Sistemi di monitoraggio
  • Cannule
  • < li>Altri

Per geografia

  • Nord America
    • Stati Uniti
    • Canada
    • Messico
  • Europa
    • Francia
    • Germania
    • Italia
    • Regno Unito
    • Spagna
    • Resto d'Europa
  • Asia Pacifico (APAC)
    • Cina
    • India
    • Corea del Sud
    • Giappone
    • Australia
    • Resto dell'APAC
  • Medio Oriente e Africa (MEA)
    • Sudafrica
    • Arabia Saudita
    • EAU
    • Resto del MEA
  • America centrale e meridionale (SCAM)
    • Brasile
    • Argentina
    • Resto dello SCAM
  • Profili aziendali

    • Getinge AB
    • Medtronic
    • LivaNova PLC
    • < li>XVIVO Perfusion
    • Terumo Cardiovascolare Systems Corporation
    • OrganOx Limited
    • Waters Medical Systems
    • TransMedics
    • Organo Sistemi di ripristino
    • XENIOS AG
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are Medical Perfusion Technology?

Perfusion is the passage of fluid through the circulatory system or lymphatic system to an organ or a tissue, usually referring to the delivery of blood to a capillary bed in tissue. Perfusion is measured as the rate at which blood is delivered to tissue, or volume of blood per unit time (blood flow) per unit tissue mass. During major surgery, perfusion must be maintained and managed by the health professionals involved, rather than left to the body's homeostasis alone.

What are the driving factors for the Medical Perfusion Technology market across the globe?

Key factors that are driving the market are rising prevalence of cardiovascular diseases, significant growth of pharmaceutical and biotechnology industries, rising need for the organ transplantation and rising cell-based research activities. However, challenging factors such as expensive organ transplant surgeries and limited numbers of donors for organ transplant surgeries are likely to show negative impact for the market in few years ahead.

What is the cost of Medical Perfusion Technology?

The costs of the medical perfusion technology are much higher, and they may cost US$ 1,0000–5,0000, or more, per software. The cost may also differ from product to product types.

The List of Companies - Medical Perfusion Technology Market

  1. Getting AB
  2. Medtronic              
  3. LivaNova PLC        
  4. Terumo Corporation          
  5. XVIVO Perfusion                 
  6. OrganOx Limited                 
  7. Waters Medical Systems LLC          
  8. TransMedics         
  9. Organ Recovery Systems                 
  10. Xenios AG - a Fresenius Medical Care company

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports